Literature DB >> 21356420

Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Daniel Ciccarone1.   

Abstract

The high prevalence of stimulant abuse and its harmful consequences make the screening, diagnosis, and referral for treatment of persons with stimulant abuse a top concern for primary care providers. Having a working knowledge of use patterns, clinical symptomatology, end-organ effects, and advances in treatment of stimulant abuse is essential. Although cocaine and amphetamine have different use patterns, duration of action, and so forth, the consequences of use are remarkably similar. Primary care is at the forefront of screening, brief risk reduction interventions, and diagnosis of medical sequelae, with referral to addiction specialist treatment when necessary.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356420      PMCID: PMC3056348          DOI: 10.1016/j.pop.2010.11.004

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  116 in total

1.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

2.  Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Authors:  David H Epstein; Wesley E Hawkins; Lino Covi; Annie Umbricht; Kenzie L Preston
Journal:  Psychol Addict Behav       Date:  2003-03

Review 3.  The contribution of impurities to the acute morbidity of illegal drug use.

Authors:  R Shesser; R Jotte; J Olshaker
Journal:  Am J Emerg Med       Date:  1991-07       Impact factor: 2.469

Review 4.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 5.  HIV infection among intravenous drug users: epidemiology and risk reduction.

Authors:  D C Des Jarlais; S R Friedman
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

6.  Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction.

Authors:  Amanda Baker; Nicole K Lee; Melissa Claire; Terry J Lewin; Tanya Grant; Sonja Pohlman; John B Saunders; Frances Kay-Lambkin; Paul Constable; Linda Jenner; Vaughan J Carr
Journal:  Addiction       Date:  2005-03       Impact factor: 6.526

7.  Factors associated with recent sildenafil (viagra) use among men who have sex with men in the United States.

Authors:  Travis H Sanchez; Kathleen M Gallagher
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

Review 8.  An overview of non-cardiac cocaine toxicity.

Authors:  Jonathan Glauser; John R Queen
Journal:  J Emerg Med       Date:  2007-01-22       Impact factor: 1.484

Review 9.  Clinical effects and management of methamphetamine abuse.

Authors:  Frank Romanelli; Kelly M Smith
Journal:  Pharmacotherapy       Date:  2006-08       Impact factor: 4.705

Review 10.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

View more
  58 in total

1.  Prior Exposure to Salient Win-Paired Cues in a Rat Gambling Task Increases Sensitivity to Cocaine Self-Administration and Suppresses Dopamine Efflux in Nucleus Accumbens: Support for the Reward Deficiency Hypothesis of Addiction.

Authors:  Jacqueline-Marie N Ferland; Tristan J Hynes; Celine D Hounjet; David Lindenbach; Cole Vonder Haar; Wendy K Adams; Anthony G Phillips; Catharine A Winstanley
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

Review 2.  Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity.

Authors:  Ying-Jian Gu; Lei Chen; Lin Cheng; Ming-Yuan Zhou; Yun Wang
Journal:  Mol Cell Biochem       Date:  2021-04-25       Impact factor: 3.396

3.  The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats.

Authors:  John J Widholm; Justin T Gass; Richard M Cleva; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-12-24

4.  Tetrahydropalmatine protects against methamphetamine-induced spatial learning and memory impairment in mice.

Authors:  Yan-Jiong Chen; Yan-Ling Liu; Qing Zhong; Yan-Fang Yu; Hong-Liang Su; Haroldo A Toque; Yong-Hui Dang; Feng Chen; Ming Xu; Teng Chen
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

Review 5.  Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Authors:  Kelly E Courtney; Lara A Ray
Journal:  Drug Alcohol Depend       Date:  2014-08-17       Impact factor: 4.492

Review 6.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

7.  Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.

Authors:  Joshua D Gross; Shane W Kaski; Adam B Schroer; Kimberley A Wix; David P Siderovski; Vincent Setola
Journal:  J Psychopharmacol       Date:  2018-01-24       Impact factor: 4.153

8.  Coronary sinus flow is reduced in methamphetamine abusers: a transthoracic echocardiographic study.

Authors:  Guang-Liang Wei; Xiao-Zhi Zheng; Ke-Qi Chen; Yun-Yan Shi; Lian-You Wang; Xu-Yan Tan
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-21       Impact factor: 2.357

9.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

10.  The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada.

Authors:  Jenna Valleriani; Rebecca Haines-Saah; Rielle Capler; Ricky Bluthenthal; M Eugenia Socias; M J Milloy; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.